Sales & Marketing News | pharmaphorum

News

MSD has agreed a $10bn takeover offer for respiratory drug specialist Verona Pharma and its fast-growing COPD therapy Ohtuvayre.

News

A new formulation of Novartis' antimalarial Coartem has become the first medicine to be approved for use in very young children.

News

KalVista has brought the first oral, on-demand treatment for hereditary angioedema attacks to the US market.

News

J&J is hoping the AMPLITUDE study results will make Akeega the first drug in the PARP inhibitor class for castration-sensitive prostate cancer.

News

The ABPI is worried about investment in medicines and moves that could limit patient and doctor treatment choice in the NHS 10-year plan.

News

AstraZeneca passes another milestone in its journey to rebuild Imfinzi's presence in bladder cancer, a key growth driver for the drug.